Barclays raised the firm’s price target on Marex Group (MRX) to $32 from $30 and keeps an Overweight rating on the shares post the Q3 report. The company’s earnings beat was driven by revenues that came in 3% ahead, somewhat offset by higher non-interest expenses, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MRX: